載入...
Effect of the monoclonal antibody TRC105 in combination with Sunitinib on renal tumor derived endothelial cells
Anti-angiogenic therapy is an important strategy to limit growth, development and expansion of solid tumors. However, resistance to VEGF-targeting agents may develop, due to activation of alternative pro-angiogenic pathways, indicating the need of multiple target strategy. Here we obtained tumor end...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5978257/ https://ncbi.nlm.nih.gov/pubmed/29854307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25206 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|